News
2d
Pharmaceutical Technology on MSNFDA rejects Stealth Bio’s Barth syndrome treatment after 16.5-month reviewStealth BioTherapeutics has cut 30% of its workforce as it eyes a resubmission based on discussions with the FDA.
At Clone, a pioneering robotics company headquartered in Poland and California, Wiktoria Kruk, Vice President of Biomechanics ...
Bio-design firm Modern Meadow will showcase its flagship offering, Innovera (fka Bio-Vera), at the Global Fashion Summit in ...
Rate this content's potential impact on patient outcomes Submit Rating Average rating / 5. Vote count: No votes so far! Be ...
Automotive OEMs are racing towards a future that needs to combine cutting-edge efficiency with first-class green credentials.
Amid geopolitical uncertainties and challenges, exhibitors at the latest Denim Première Vision had a clear vision that ...
Generation Bio Co. (Nasdaq:GBIO), a biotechnology company working to change what’s possible for people living with T cell-driven autoimmune diseases, announced that Geoff McDonough, M.D., president ...
With innovative features like One-Tap Infinix AI∞, a sleek true-metal frame and new charging capabilities, the NOTE 50 Pro ...
Debates over AI antibody design terminology have clouded the industry’s shared mission of bringing better therapeutics to the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results